Source: Eur Respir J 2014; 43: 635-638
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Bennett David, Bargagli Elena, Refini Rosa Metella, Campagna Maria Stella, Gennari Luigi, Nuti Ranuccio, Figura Natale, Rottoli Paola. Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis. Eur Respir J 2014; 43: 635-638

Member's Comments

No comment yet.

Related content which might interest you: Helicobacter pylori seroprevalence in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 486s Year: 2006 Helicobacter pylori eradication in the management of idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: 395-396 Year: 2007 Helicobacter pylori seroprevalence in patients with chronic bronchitis Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 Helicobacter pylori antibody positivity in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Helicobacter pylori seroprevalence in patients with asthma, bronchiectasis, lung cancer and pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 323s Year: 2006 Is there any role of Helicobacter pylori in the pathogenesis of bronchiectasis? Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008 The investigation of the existence of Helicobacter pylori in the bronchoscopic lung specimens of patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 217s Year: 2001 Hyperergic reactions on Helicobacter pylori infection in patients with asthma contributes to stomach mucosa damage Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007 Helicobacter pylori in bronchiectasis: a study of PCR assay in lung tissue of operated patients Source: Eur Respir J 2003; 22: Suppl. 45, 515s Year: 2003 Detection of helicobacter pylori by PCR in idiopathic pulmonary fibrosis (IPF) lung biopsies Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Seroprevalence of chlamydophila pneumoniae in patients with moderate exacerbation of COPD Source: Annual Congress 2006 - Pathophysiology and treatment of infections in COPD Year: 2006 The presence of Helicobacter pylori in tumor-free samples of bronchial biopsies of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 The association between Chlamydia pneumoniae chronic infection and inflammation in COPD patients. Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Predictors of eradication failure at first isolation of MRSA in cystic fibrosis patients Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 The efficacy of early eradication therapy in prevention of chronic pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 486s Year: 2006 Infection with Chlamydia pneumoniae in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 539s Year: 2001 Survey of microbiology, pseudomonas eradication and antimicrobial prophylaxis in adult patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Prevalence of hyperglycaemia during infective exacerbation in adult cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007 Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020 The diagnostic value of pseudomonas aeruginosa serology as markers of early respiratory infection in young children with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage Year: 2007